Literature DB >> 9060704

Replication-competent chimeric lenti-oncovirus with expanded host cell tropism.

S Reiprich1, B R Gundlach, B Fleckenstein, K Uberla.   

Abstract

Baboon bone marrow was grafted into human immunodeficiency virus type 1-infected patients in the course of recent trials for AIDS treatment. Since the baboon genome harbors multiple copies of an endogenous oncovirus, chimeric lenti-oncoviruses could emerge in the xenotransplant recipient. To analyze the potential replication competence of hybrid viruses between different genera of retroviruses, we replaced most of the env gene of simian immunodeficiency virus with the env gene of an amphotropic murine leukemia virus. The hybrid virus could be propagated in human T-cell lines, in peripheral blood mononuclear cells of rhesus macaques, and in CD4- B-cell lines. Because of the expanded cell tropism, the hybrid virus might have a selective advantage in comparison to parental viruses. Therefore, emerging chimeric viruses may be considered a serious risk of xenotransplantation. A note of caution is also suggested for the use of pseudotyped lentiviral vectors for human gene therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060704      PMCID: PMC191473     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  Retroviral recombination and reverse transcription.

Authors:  W S Hu; H M Temin
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

3.  The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.

Authors:  D A Regier; R C Desrosiers
Journal:  AIDS Res Hum Retroviruses       Date:  1990-11       Impact factor: 2.205

4.  A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses.

Authors:  S Y Le; M H Malim; B R Cullen; J V Maizel
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

5.  Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.

Authors:  Y M Naidu; H W Kestler; Y Li; C V Butler; D P Silva; D K Schmidt; C D Troup; P K Sehgal; P Sonigo; M D Daniel
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.

Authors:  L H Evans; R P Morrison; F G Malik; J Portis; W J Britt
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range.

Authors:  N R Landau; K A Page; D R Littman
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class.

Authors:  J W Hartley; W P Rowe
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

9.  Propagation of SIV vectors by genetic complementation with a heterologous env gene.

Authors:  T A Rizvi; A T Panganiban
Journal:  AIDS Res Hum Retroviruses       Date:  1992-01       Impact factor: 2.205

10.  HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages.

Authors:  A McKnight; P R Clapham; R A Weiss
Journal:  Virology       Date:  1994-05-15       Impact factor: 3.616

View more
  5 in total

1.  A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.

Authors:  Mary Jane Potash; Wei Chao; Galina Bentsman; Nicolae Paris; Manisha Saini; Jadwiga Nitkiewicz; Paula Belem; Leroy Sharer; Andrew I Brooks; David J Volsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

2.  Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry.

Authors:  S Pöhlmann; B Lee; S Meister; M Krumbiegel; G Leslie; R W Doms; F Kirchhoff
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines.

Authors:  B R Gundlach; S Reiprich; S Sopper; R E Means; U Dittmer; K Mätz-Rensing; C Stahl-Hennig; K Uberla
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry.

Authors:  F Kirchhoff; S Pöhlmann; M Hamacher; R E Means; T Kraus; K Uberla; P Di Marzio
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Live bacterial vaccines--a review and identification of potential hazards.

Authors:  Ann Detmer; Jacob Glenting
Journal:  Microb Cell Fact       Date:  2006-06-23       Impact factor: 5.328

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.